Skip to main content
. 2021 Feb 15;1233:130094. doi: 10.1016/j.molstruc.2021.130094

Table 3.

Bioactivity prediction of the Nafamostat and VR23 through Molinspiration software.

Inhibitors GPCR ligand Ion channel modulator Kinase Inhibitor Nuclear receptor ligand Protease Inhibitor Enzyme Inhibitor
Nafamostat 0.28 0.14 −0.03 −0.16 0.57 0.19
VR23 −0.05 −0.15 −0.04 −0.32 0.07 0.05